Are you Dr. Sherwat?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 32 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3800 Reservoir Rd Nw
Washington, DC 20007Phone+1 202-687-6845
Summary
- Dr. Adam Sherwat, MD is an infectious disease specialist in Washington, District of Columbia. He is currently licensed to practice medicine in Maryland. He is an Assistant Professor at Georgetown University School of Medicine.
Education & Training
- MedStar Health/Georgetown University HospitalFellowship, Infectious Disease, 2003 - 2005
- Christ HospitalResidency, Internal Medicine, 1996 - 1999
- University of Cincinnati College of MedicineClass of 1996
Certifications & Licensure
- MD State Medical License 2008 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 122 citationsFDA Approval of Remdesivir - A Step in the Right Direction.Daniel B. Rubin, Kirk M Chan-Tack, John Farley, Adam Sherwat
The New England Journal of Medicine. 2020-12-02 - 10 citationsDoes an increase in serum creatinine always reflect renal injury? The case of Stribild®Vikram Arya, Jeffry Florian, Kendall A. Marcus, Kellie S. Reynolds, Linda L. Lewis
Journal of Clinical Pharmacology. 2014-03-01 - 79 citationsTecovirimat and the Treatment of Monkeypox - Past, Present, and Future Considerations.Adam Sherwat, John T Brooks, Debra Birnkrant, Peter Kim
The New England Journal of Medicine. 2022-08-18
Press Mentions
- Sept. 16, 2022: National Advocacy UpdateSeptember 16th, 2022
- FDA Warns Monkeypox Could Mutate if Antiviral Drug Is OverusedSeptember 14th, 2022
- What Physicians Need to Know About Tecovirimat (TPOXX) for Treatment of MonkeypoxSeptember 13th, 2022
- Join now to see all